HonorHealth Research Institute
Amount: $100,000
Award date: 2026
Duration: 18 months
Program area: Bioscience
Translational Seed Grant: Glioblastoma Multiforme (GBM) remains a formidable clinical challenge with limited efficacy of current immunotherapies. The team has developed a therapy to rapidly identify tumor-specific targets unique to each patient, triggering more effective tumor cell killing.